Get to know Dova better with 9 real example sentences.
Using Dova
- In the example corpus, dova often appears in combinations such as: dova pharmaceuticals, upgraded dova.
Context around Dova
- Average sentence length in these examples: 21.8 words
- Position in the sentence: 8 start, 1 middle, 0 end
- Sentence types: 9 statements, 0 questions, 0 exclamations
Corpus analysis for Dova
- In this selection, "dova" usually appears near the start of the sentence. The average example has 21.8 words, and this corpus slice is mostly made up of statements.
- Around the word, upgraded, pharmaceuticals, acquired and reported stand out and add context to how "dova" is used.
- Recognizable usage signals include avotrombopag which dova acquired from and bidaskclub upgraded dova pharmaceuticals from. That gives this page its own corpus information beyond isolated example sentences.
- By corpus frequency, "dova" sits close to words such as aakash, aanholt and aardwolf, which helps place it inside the broader word index.
Example types with dova
The same corpus examples are grouped by length and sentence type, making it easier to see the contexts in which the word appears:
Dova reported in 2018 revenue for the drug. (8 words)
Dova Pharmaceuticals, Inc) related to its sale to Swedish Orphan Biovirtum AB. (12 words)
However, it's a good thing that Dova is also expanding the drug into other indications. (16 words)
Avotrombopag, which Dova acquired from Japanese pharmaceutical company Eisai in 2016, is designed to mimic a hormone produced in the liver and kidney that plays a role in the body’s platelet production process. (34 words)
Evercore ISI upgraded Dova Pharmaceuticals from an “in-line” rating to an “outperform” rating and set a $15.00 price target on the stock in a report on Monday, July 1st. (31 words)
Four analysts have issued estimates for Dova Pharmaceuticals’ earnings, with the highest sales estimate coming in at $4.05 million and the lowest estimate coming in at $3.00 million. (30 words)
Example sentences (9)
Avotrombopag, which Dova acquired from Japanese pharmaceutical company Eisai in 2016, is designed to mimic a hormone produced in the liver and kidney that plays a role in the body’s platelet production process.
BidaskClub downgraded shares of Dova Pharmaceuticals from a “buy” rating to a “hold” rating in a research note on Wednesday, June 5th.
Dova Pharmaceuticals, Inc) related to its sale to Swedish Orphan Biovirtum AB.
Dova reported in 2018 revenue for the drug.
Evercore ISI upgraded Dova Pharmaceuticals from an “in-line” rating to an “outperform” rating and set a $15.00 price target on the stock in a report on Monday, July 1st.
Finally, BidaskClub upgraded Dova Pharmaceuticals from a “buy” rating to a “strong-buy” rating in a report on Friday.
Four analysts have issued estimates for Dova Pharmaceuticals’ earnings, with the highest sales estimate coming in at $4.05 million and the lowest estimate coming in at $3.00 million.
However, it's a good thing that Dova is also expanding the drug into other indications.
The Dova and Sobi boards of directors have both approved the acquisition, which is expected to close in the fourth quarter of this year.
Common combinations with dova
These word pairs occur most frequently in English texts: